Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Mailman

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
Journal of Medicinal Chemistry|June 23, 1995
Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H- benzo[6,7]cyclohepta[1,2,3-ef][3]benzazepine, 6,7-dihydroxy- 1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd]azepine, and 10-(aminomethyl)-9,10- dihydro-1,2-dihydroxyanthracene as conformationally restricted analogs of beta-phenyldopamineS E Snyder, F A Aviles-Garay, R Chakraborti, et al.
Psychopharmacology|January 1, 1980
An evaluation of the selectivity of fenmetozole (DH-524) reversal of ethanol-induced changes in central nervous system functionG D Frye, G R Breese, R B Mailman, et al.
Psychopharmacology|January 1, 1981
Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activityM G Ondrusek, C D Kilts, G D Frye, et al.
Biological Psychiatry|December 4, 1998
Serotonergic basis of antipsychotic drug effects in schizophreniaJ A Lieberman, R B Mailman, G Duncan, et al.
Brain Research|April 14, 1978
Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neuronsR J Konkol, R B Mailman, E G Bendeich, et al.
Journal of Medicinal Chemistry|December 9, 1994
Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonistsD L Minor, S D Wyrick, P S Charifson, et al.
Brain Research|November 3, 1978
Effects of acute administration of monosodium-L-glutamate (MSG), atropine or haloperidol on anterior pituitary hormone secretion in the ratC B Nemeroff, G Bissette, G H Greeley, et al.
Journal of Medicinal Chemistry|January 5, 1996
Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mappingD M Mottola, S Laiter, V J Watts, et al.
Neuroscience|August 6, 1998
Behavioural assessment of mice lacking D1A dopamine receptorsD R Smith, C D Striplin, A M Geller, et al.
Journal of Medicinal Chemistry|March 12, 1999
Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quineloraneM K Doll, D E Nichols, J D Kilts, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Journal of Medicinal Chemistry|June 23, 1995
Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H- benzo[6,7]cyclohepta[1,2,3-ef][3]benzazepine, 6,7-dihydroxy- 1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd]azepine, and 10-(aminomethyl)-9,10- dihydro-1,2-dihydroxyanthracene as conformationally restricted analogs of beta-phenyldopamineS E Snyder, F A Aviles-Garay, R Chakraborti, et al.
Psychopharmacology|January 1, 1980
An evaluation of the selectivity of fenmetozole (DH-524) reversal of ethanol-induced changes in central nervous system functionG D Frye, G R Breese, R B Mailman, et al.
Psychopharmacology|January 1, 1981
Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activityM G Ondrusek, C D Kilts, G D Frye, et al.
Biological Psychiatry|December 4, 1998
Serotonergic basis of antipsychotic drug effects in schizophreniaJ A Lieberman, R B Mailman, G Duncan, et al.
Brain Research|April 14, 1978
Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neuronsR J Konkol, R B Mailman, E G Bendeich, et al.
Journal of Medicinal Chemistry|December 9, 1994
Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonistsD L Minor, S D Wyrick, P S Charifson, et al.
Brain Research|November 3, 1978
Effects of acute administration of monosodium-L-glutamate (MSG), atropine or haloperidol on anterior pituitary hormone secretion in the ratC B Nemeroff, G Bissette, G H Greeley, et al.
Journal of Medicinal Chemistry|January 5, 1996
Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mappingD M Mottola, S Laiter, V J Watts, et al.
Neuroscience|August 6, 1998
Behavioural assessment of mice lacking D1A dopamine receptorsD R Smith, C D Striplin, A M Geller, et al.
Journal of Medicinal Chemistry|March 12, 1999
Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quineloraneM K Doll, D E Nichols, J D Kilts, et al.
Pageof 16